<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16647</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2017-21-2-270-280</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">SHORT- AND LONG-TERM OUTCOMES OF SELECTIVE PROSTATIC ARTERY EMBOLIZATION IN PATIENT HIGH SURGICAL AND ANESTESILOGICAL RISK</article-title><trans-title-group xml:lang="ru"><trans-title>НЕПОСРЕДСТВЕННЫЕ И ОТДАЛЕННЫЕ РЕЗУЛЬТАТЫ ЭМБОЛИЗАЦИИ ПРОСТАТИЧЕСКИХ АРТЕРИЙ У БОЛЬНЫХ С ДОБРОКАЧЕСТВЕННОЙ ГИПЕРПЛАЗИЕЙ ПРОСТАТЫ ВЫСОКОГО ХИРУРГИЧЕСКОГО И АНЕСТЕЗИОЛОГИЧЕСКОГО РИСКА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zharikov</surname><given-names>S B</given-names></name><name xml:lang="ru"><surname>Жариков</surname><given-names>С Б</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. отделением ФГБУ «3 Центральный военный клинический госпиталь им. А.А. Вишневского» МО РФ</p></bio><email>hospital_dms@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Roslik</surname><given-names>S S</given-names></name><name xml:lang="ru"><surname>Рослик</surname><given-names>С С</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsymbal</surname><given-names>E V</given-names></name><name xml:lang="ru"><surname>Цымбал</surname><given-names>Е В</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ivanov</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Иванов</surname><given-names>В А</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kochetov</surname><given-names>A G</given-names></name><name xml:lang="ru"><surname>Кочетов</surname><given-names>А Г</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Esipov</surname><given-names>A V</given-names></name><name xml:lang="ru"><surname>Есипов</surname><given-names>А В</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karabach</surname><given-names>I V</given-names></name><name xml:lang="ru"><surname>Карабач</surname><given-names>И В</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khayrutdinov</surname><given-names>E R</given-names></name><name xml:lang="ru"><surname>Хайрутдинов</surname><given-names>Е Р</given-names></name></name-alternatives><email>konovalov_oe@rudn.university</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">3rd Central military clinical hospital n.a. Vishnevsky, Krasnogorsk, Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «3 Центральный военный клинический госпиталь им. А.А. Вишневского» Министерства Обороны РФ, Красногорск, Россия</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">RUDN University, Moscow, Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов, Москва, Россия</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Botkin hospital, Moscow, Russia</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница им. С.П. Боткина, Москва, Россия</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><volume>21</volume><issue>2</issue><issue-title xml:lang="en">VOL 21, NO2 (2017)</issue-title><issue-title xml:lang="ru">ТОМ 21, №2 (2017)</issue-title><fpage>270</fpage><lpage>280</lpage><history><date date-type="received" iso-8601-date="2017-09-09"><day>09</day><month>09</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Zharikov S.B., Roslik S.S., Tsymbal E.V., Ivanov V.A., Kochetov A.G., Esipov A.V., Karabach I.V., Khayrutdinov E.R.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Жариков С.Б., Рослик С.С., Цымбал Е.В., Иванов В.А., Кочетов А.Г., Есипов А.В., Карабач И.В., Хайрутдинов Е.Р.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Zharikov S.B., Roslik S.S., Tsymbal E.V., Ivanov V.A., Kochetov A.G., Esipov A.V., Karabach I.V., Khayrutdinov E.R.</copyright-holder><copyright-holder xml:lang="ru">Жариков С.Б., Рослик С.С., Цымбал Е.В., Иванов В.А., Кочетов А.Г., Есипов А.В., Карабач И.В., Хайрутдинов Е.Р.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/16647">https://journals.rudn.ru/medicine/article/view/16647</self-uri><abstract xml:lang="en"><p>Prostate artery embolization has garnered much attention as a promising treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Current evidence suggests it is a safe and effective option for patients with medication-refractory urinary obstructive symptoms who are poor surgical candidates or refuse surgical therapy.</p></abstract><trans-abstract xml:lang="ru"><p>Селективная эмболизация простатических артерий (ЭПА) в настоящее время рассматривается в качестве перспективного малоинвазивного метода лечения синдрома нижних мочевых путей (СНМП) у больных с доброкачественной гиперплазией простаты (ДГП). Целью нашего исследования явилось изучение непосредственных и отдаленных результатов ЭПА у больных с тяжелыми клиническими проявлениями СНМП, рефрактерными к медикаментозной терапии и невозможностью выполнения традиционных хирургических гисторедукционных вмешательств на простате. Полученные результа-ты свидетельствуют о высокой эффективности ЭПА как в отношении уменьшения явлений СНМП, так и для создания условий к удалению цистостомических катетеров. Отсутствие «больших» осложнений доказывает безопасность применения ЭПА у больных изучаемой группы.</p></trans-abstract><kwd-group xml:lang="en"><kwd>prostatic artery embolization</kwd><kwd>benign prostate hyperplasia</kwd><kwd>lower urinary tract syndrome</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эмболизация простатических артерий</kwd><kwd>доброкачественная гиперплазия про-статы</kwd><kwd>синдром нижних мочевых путей</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Korneev I.A., Aleksseva T.A., Kogan M.I. &amp; Pushkar D.Yu. Epidemiology of urinary disorders in men in the Russian Federation. Uorologiia. 2016. 2 (suppl.). С. 70—75.</mixed-citation><mixed-citation xml:lang="ru">Корнеев И.А., Алексеева Т.А., Коган М.И., Пушкарь Д.Ю. Эпидемиология расстройств мочеиспускания у мужчин Российской Федерации // Урология. 2016. 2 (приложение): 70-75.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Irwin D., Kopp Z. &amp; Agatep B. Worldwide prevalence estimates of lower urynary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011. 108: 1132—1138.</mixed-citation><mixed-citation xml:lang="ru">Irwin D., Kopp Z., Agatep B. Worldwide prevalence estimates of lower urynary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction // BJU Int. 2011. 108:1132-1138.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Mcvary K., Roehrborn A. &amp; Descazeaud A. EAU guidelines on the assessment on non-neuro¬genic male lower urinary tract symptoms including benigh prostatic obstruction. Eur Urol. 2015. 67:1099—1109.</mixed-citation><mixed-citation xml:lang="ru">Mcvary K., Roehrborn A., Descazeaud A. EAU guidelines on the assessment on non-neurogenic male lower urinary tract symptoms including benigh prostatic obstruction // Eur Urol. 2015. 67:1099-1109.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Ahyai S., Gilling P. &amp; Kaplan S. Meta-Analysis of functional outcomes and complications follow-ing transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010. 58:384—397.</mixed-citation><mixed-citation xml:lang="ru">Ahyai S., Gilling P., Kaplan S. Meta-Analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement // Eur Urol. 2010. 58:384-397.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">McWilliams J.P. et al. Society of Interventional Radiology position statement: prostate artery em-bolization for treatment of benign disease of the prostate. J Vasc Interv Radiol. 2014;25(9): 1349—51.</mixed-citation><mixed-citation xml:lang="ru">McWilliams J.P. et al. Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate //J Vasc Interv Radiol. 2014; 25(9):1349-51</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">DeMeritt J.S., Elmasri F.F., Esposito M.P. &amp; Rosenberg G.S. Relief of benign prostatic hyperpla-sia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000;11(6):767—70.</mixed-citation><mixed-citation xml:lang="ru">DeMeritt J.S., Elmasri F.F., Esposito M.P., Rosenberg G.S. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization // J Vasc Interv Radiol. 2000;11(6):767-70.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Sun F., Sanchez F.M., Crisostomo V., Lima J.R., Luis L., Garcıa-Martınez V., Lopez-Sanchez C., Uson J. &amp; Maynar M. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment-preliminary study in pigs. Radiology. 2008. 246(3):783—9.</mixed-citation><mixed-citation xml:lang="ru">Sun F., Sanchez F.M., Crisostomo V., Lima J.R., Luis L., Garcıa-Martınez V., Lopez-Sanchez C., Uson J., Maynar M. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment-preliminary study in pigs // Radiology. 2008. 246(3):783-9.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Mauro M.A. Can hyperplastic prostate follow uterine fibroids and be managed with transcatheter arterial embolization? Radiology. 2008. 246(3):657—8.</mixed-citation><mixed-citation xml:lang="ru">Mauro M.A. Can hyperplastic prostate follow uterine fibroids and be managed with transcatheter arterial embolization? // Radiology. 2008. 246(3):657-8.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Faintuch S., Mostafa E.M., Carnevale F.C., Ganguli S., Rabkin D.J. &amp; Goldberg S.N. Prostatic ar-tery embolization as a primary treatment for benign prostatic hyperplasia in a canine model (ab-stract). J Vasc Interv Radiol. 2008;19(2):S1—210.</mixed-citation><mixed-citation xml:lang="ru">Faintuch S., Mostafa E.M., Carnevale F.C., Ganguli S., Rabkin D.J., Goldberg S.N. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia in a canine model (abstract) // J Vasc Interv Radiol. 2008;19(2):S1-210.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Carnevale F.C., Antunes A.A., da Motta Leal Filho J.M., de Oliveira Cerri L.M., Baroni R.H., Marcelino A.S., Freire G.C., Moreira A.M., Srougi M. &amp; Cerri G.G. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Car-diovasc Intervent Radiol. 2010;33(2):355—61.</mixed-citation><mixed-citation xml:lang="ru">Carnevale F.C., Antunes A.A., da Motta Leal Filho J.M., de Oliveira Cerri L.M., Baroni R.H., Marcelino A.S., Freire G.C., Moreira A.M., Srougi M., Cerri G.G. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients // Cardiovasc Intervent Radiol. 2010;33(2):355-61.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">McWilliams J.P., Kuo M.D., Rose S.C., Bagla S., Caplin D.M., Cohen E.I., Faintuch S., Spies J.B., Saad W.E. &amp; Nikolic B. Society of interventional radiology position statement: prostate ar-tery embolization for treatment of benign disease of the prostate. J Vasc Interv Radiol. 2014; 25(9):1349—51.</mixed-citation><mixed-citation xml:lang="ru">McWilliams J.P., Kuo M.D., Rose S.C., Bagla S., Caplin D.M., Cohen E.I., Faintuch S., Spies J.B., Saad W.E., Nikolic B. Society of interventional radiology position statement: prostate artery embolization for treatment of benign disease of the prostate // J Vasc Interv Radiol. 2014; 25(9):1349-51.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Antunes A.A., Carnevale F.C., da Motta Leal Filho J.M., Yoshinaga E.M., Cerri L.M.O., Baroni R.H., et al. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia: a prospective, single-center pilot study. Cardiovasc Interv Radiol. 2013. 4: 978—986.</mixed-citation><mixed-citation xml:lang="ru">Antunes A.A., Carnevale F.C., da Motta Leal Filho J.M., Yoshinaga E.M., Cerri L.M.O., Baroni R.H., et al. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia: a prospective, singlecenter pilot study // Cardiovasc Interv Radiol. 2013. 4: 978-986.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Moreira A.M., Marques C.F.S., Antunes A.A., Nahas C.S.R., Nahas S.C., de Gregorio Ariza M.A., et al. Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature. Cardiovasc Interv Radiol. 2013. 6: 1690—1694.</mixed-citation><mixed-citation xml:lang="ru">Moreira A.M., Marques C.F.S., Antunes A.A., Nahas C.S.R., Nahas S.C., de Gregorio Ariza M.A., et al. Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature // Cardiovasc Interv Radiol. 2013. 6: 1690-1694.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Pisco J.M., Pinheiro L.C., Bilhim T., Duarte M., Mendes J.R. &amp; Oliveira A.G. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2011. 22:11—9.</mixed-citation><mixed-citation xml:lang="ru">Pisco J.M., Pinheiro L.C., Bilhim T., Duarte M., Mendes J.R., Oliveira A.G. Prostatic arterial embolization to treat benign prostatic hyperplasia // J Vasc Interv Radiol. 2011. 22:11-9.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Grosso M., Balderi A., Arno` M., Sortino D., Antonietti A., Pedrazzini R., et al. Prostatic artery embolization in benign pro- static hyperplasia: preliminary results in 13 patients. Radiol Med. 2014. 34:23—29.</mixed-citation><mixed-citation xml:lang="ru">Grosso M., Balderi A., Arno` M., Sortino D., Antonietti A., Pedrazzini R., et al. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients // Radiol Med. 2014. 34:23-29.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Lin Y.T., Amouyal G., Thiounn N., Pellerin O., Pereira H., Del Giudice C., et al. Intravesical prostatic protrusion (IPP) can be reduced by prostatic artery embolization. Cardiovasc Interv Ra-diol. 2015. 45:21—28.</mixed-citation><mixed-citation xml:lang="ru">Lin Y.T., Amouyal G., Thiounn N., Pellerin O., Pereira H., Del Giudice C., et al. Intravesical prostatic protrusion (IPP) can be reduced by prostatic artery embolization // Cardiovasc Interv Radiol. 2015. 45:21-28.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Sun F., Sanchez F.M., Crisostomo V., Lima J.R., Luis L., Garcıa-Martınez V., Lopez-Sanchez C., Uson J., Maynar M. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment-preliminary study in pigs. Radiology. 2008. 246(3):783—9.</mixed-citation><mixed-citation xml:lang="ru">Sun F., Sanchez F.M., Crisostomo V., Lima J.R., Luis L., Garcıa-Martınez V., Lopez-Sanchez C., Uson J., Maynar M. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment-preliminary study in pigs // Radiology. 2008. 246(3):783-9.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Carnevale F.C., Antunes A.A., da Motta Leal Filho J.M., Cerri L.M.O., Baroni R.H., Mar¬celino A.S.Z., et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Interv Radiol. 2010. 2:355—361.</mixed-citation><mixed-citation xml:lang="ru">Carnevale F.C., Antunes A.A., da Motta Leal Filho J.M., Cerri L.M.O., Baroni R.H., Marcelino A.S.Z., et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients // Cardiovasc Interv Radiol. 2010. 2:355-361.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Pisco J., Pinheiro L.C., Bilhim T., Duarte M., Rio Tinto H., Fernandes L., et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013. 2: 668—677.</mixed-citation><mixed-citation xml:lang="ru">Pisco J., Pinheiro L.C., Bilhim T., Duarte M., Rio Tinto H., Fernandes L., et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results // Radiology. 2013. 2: 668-677.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Kurbatov D., Russo G.I., Lepetukhin A., Dubsky S., Sitkin I., Morgia G. Prostatic artery emboliza-tion for prostate volume greater than 80 cm3: results from a single-center prospective stude. Urol-ogy. 2014. 84:400—404.</mixed-citation><mixed-citation xml:lang="ru">Kurbatov D., Russo G.I., Lepetukhin A., Dubsky S., Sitkin I., Morgia G. Prostatic artery embolization for prostate volume greater than 80 cm: results from a single-center prospective stude // Urology. 2014. 84:400-404.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Wang M.Q., Wang Y., Yan J.Y., Yuan K., Zhang G.D., Duan F., Li K. Prostatic artery emboliza-tion for the treatment of symptomatic benign prostatic hyperplasia in men C75 years: a prospective single-center study. World J Urol. 2016. 34:1275—1283.</mixed-citation><mixed-citation xml:lang="ru">Wang M.Q., Wang Y., Yan J.Y., Yuan K., Zhang G.D., Duan F., Li K. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men C75 years: a prospective single-center study // World J Urol. 2016. 34:1275-1283.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
